ABEV
Ambev SA ADR
Ambev SA ADR historical holders
total: 6
AKO Capital Ambev SA ADR transactions over time
- Total transactions:
- 17
- New positions:
- 1
- Sold out:
- 1
- Added:
- 12
- Reduced:
- 3
- Held since:
- 2017 Q3
- Held for:
- 16 quarters
- Latest activity:
- 2021 Q3
Nicolai Tangen has been an institutional investor in Ambev SA ADR (ABEV) since 2017 Q3. According to 2026 Q1 report, Nicolai Tangen doesn't hold any shares. The fund/company first acquired ABEV in 2017 Q3, initially purchasing about 4.54M shares. Since the initial investment, AKO Capital has made 16 more transactions in this position.
When did Nicolai Tangen exit their ABEV position?
Nicolai Tangen no longer holds Ambev SA ADR (ABEV). They sold off their entire position in 2021 Q3, closing out an investment that began in 2017 Q3.
When did Nicolai Tangen first invest in ABEV?
Nicolai Tangen first invested in Ambev SA ADR (ABEV) in 2017 Q3 at the reported quarter-end price of $0.23 per share, acquiring 4,544,467 shares in their initial purchase.
What is Nicolai Tangen's average cost basis for ABEV?
Based on historical transaction data, Nicolai Tangen's estimated cost basis for Ambev SA ADR (ABEV) is approximately $3.53 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $3.53
- Weighted AVG sell price:
- $3.26
ABEV transactions history by AKO Capital
17 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$3.44
|
|
-100% (-33,058,851)
|
-1.28%
|
|
2021 Q2
|
1.28%
|
33,058,851
|
$3.44
|
$113,722,000
|
+0.70% (+230,876)
|
+0.01%
|
|
2021 Q1
|
1.11%
|
32,827,975
|
$2.74
|
$89,949,000
|
-0.16% (-53,241)
|
-0%
|
|
2020 Q4
|
1.30%
|
$3.06
|
-33.56% (-16,612,266)
|
|||
|
2020 Q3
|
1.76%
|
$2.26
|
-4.50% (-2,329,849)
|
|||
|
2020 Q2
|
2.39%
|
$2.64
|
+10.10% (+4,755,800)
|
|||
|
2020 Q1
|
2.28%
|
$2.30
|
+20.40% (+7,975,590)
|
|||
|
2019 Q4
|
3.92%
|
$4.66
|
+12.62% (+4,382,063)
|
|||
|
2019 Q3
|
3.90%
|
$4.62
|
+7.26% (+2,348,948)
|
|||
|
2019 Q2
|
3.84%
|
$4.67
|
+22.22% (+5,882,307)
|
|||
|
2019 Q1
|
3.44%
|
$4.30
|
+57.30% (+9,645,604)
|
|||
|
2018 Q4
|
2.97%
|
$3.92
|
+86.46% (+7,805,336)
|
|||
|
2018 Q3
|
2.11%
|
$4.57
|
+22.72% (+1,671,617)
|
|||
|
2018 Q2
|
1.84%
|
$4.63
|
+9.10% (+613,699)
|
|||
|
2018 Q1
|
2.90%
|
$7.27
|
+25.34% (+1,363,099)
|
|||
|
2017 Q4
|
0.03%
|
$0.06
|
+18.37% (+834,801)
|
|||
|
2017 Q3
|
0.08%
|
$0.23
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.